Winton Group’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
Other funds holding AVIR
BCM
Winton Group's AVIR Position: Q3 2026 in Review
Winton Group opened a new position in Atea Pharmaceuticals (AVIR) in Q3 2026: 43,700 shares worth $228K. The stake represents 0.01% of the portfolio and ranks #912 among its holdings.
102 funds tracked by Wall St. Rank hold AVIR as of Q3 2026.
- Winton Group held 43,700 shares of Atea Pharmaceuticals worth $228K as of Q3 2026.
- Atea Pharmaceuticals was a new Winton Group position in Q3 2026.
- Atea Pharmaceuticals made up 0.01% of Winton Group's portfolio in Q3 2026, its #912 holding.
- 102 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q3 2026.
Based on Winton Group's 13F filing for Q3 2026, filed 12 Nov 2026.